Testosterone isovalerate
Jump to navigation
Jump to search
| File:Testosterone isovalerate.svg | |
| Clinical data | |
|---|---|
| Other names | Testosterone isopentanoate; Testosterone 17β-isovalerate; Androst-4-en-17β-ol-3-one 17β-isovalerate |
| Routes of administration | Intramuscular injection |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C24H36O3 |
| Molar mass | 372.549 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Testosterone isovalerate, also known as testosterone isopentanoate, testosterone 17β-isovalerate, and androst-4-en-17β-ol-3-one 17β-isovalerate, is a synthetic, injected anabolic-androgenic steroid (AAS) and an androgen ester – specifically, the C17β isovalerate (isopentanoate) ester of testosterone – which was never marketed.[1][2] It is a prodrug of testosterone and, when administered via intramuscular injection, is associated with a long-lasting depot effect and extended duration of action.[1]
See also
[edit | edit source]References
[edit | edit source]